Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm
NCT06582186 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2024-09-03
Summary
The goal of this interventional single-arm study is to evaluate the interest of a multiparametric algorithm for individualization of first voriconazole maintenance doses for improvement of initial voriconazole exposure in adult patients with haematological malignancies. The main objective it aims is to determine the percentage of patients with initial voriconazole trough concentrations in the therapeutic range after individualization of first maintenance doses.
Participants will benefited from individualization of first voriconazole maintenance doses through a previously developed and validated multiparametric algorithm (publication in progress) taking into account CYP2C19 genotype, C reactive protein level and age.
Conditions
- Aspergillosis Invasive
- Fungal Infection
- Hematologic Malignancy
Interventions
- DRUG
-
Individualization of first voriconazole maintenance doses
Individualization of first voriconazole maintenance doses
Sponsors & Collaborators
-
University Hospital, Grenoble
lead OTHER
Principal Investigators
-
Gautier-Veyret Elodie · Grenoble Alps University Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-31
- Primary Completion
- 2027-10-31
- Completion
- 2027-10-31
Countries
- France
Study Locations
More Related Trials
-
CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels
NCT03731169 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001810 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
NCT01416025 ·Status: COMPLETED ·Phase: PHASE4
-
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
NCT00059878 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy
NCT04238884 ·Status: UNKNOWN ·Phase: PHASE4
-
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
NCT00445952 ·Status: COMPLETED
-
Voriconazole to Prevent Systemic Fungal Infections in Children
NCT00005912 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001757 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients
NCT01321372 ·Status: COMPLETED
-
Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy
NCT01148160 ·Status: TERMINATED
-
A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis
NCT00423163 ·Status: WITHDRAWN ·Phase: PHASE4
-
Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)
NCT00289991 ·Status: COMPLETED ·Phase: PHASE3
-
Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
NCT00531479 ·Status: COMPLETED ·Phase: PHASE3
-
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
NCT00001646 ·Status: COMPLETED ·Phase: PHASE3
-
Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT00079222 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
NCT01782131 ·Status: COMPLETED ·Phase: PHASE3
-
Voriconazole For Chronic Bronchopulmonary Aspergillosis
NCT00159822 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study
NCT06069505 ·Status: RECRUITING
-
A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents
NCT00556998 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole
NCT01080651 ·Status: COMPLETED ·Phase: PHASE1
-
F901318 Single Ascending Dose Study in Healthy Male Volunteers
NCT02142153 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Doses of Itraconazole and Voriconazole Are Given to Healthy Volunteers
NCT03515382 ·Status: COMPLETED ·Phase: PHASE1
-
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
NCT00066599 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
NCT06510699 ·Status: RECRUITING ·Phase: PHASE2
-
Pharmacologic Optimization of Voriconazole
NCT00893555 ·Status: COMPLETED ·Phase: PHASE3